Beyond Antibiotics: Translation and Impact
Wednesday, 11 June - Thursday, 12 June 2025
St Hugh's College, Oxford
The Oxford AMR Network in collaboration with the Ineos Oxford Institute for antimicrobial research and Beyond Antibiotics (an EPRSC-funded programme) is hosting a two-day conference for members of the University of Oxford working on antimicrobial resistance (AMR).
The conference will bring together experts from academia, industry, healthcare and policy to advocate for AMR research and identify opportunities for translational research.
The two-day conference will include a translational workshop, researcher sandpit to facilitate collaborations, poster presentations and a AMR communications and engagement session.
Registration for the event is now closed..
Keynote speaker
Prof Angela Huttner
Head of Infectious Diseases, Geneva University Hospitals
Scene setting
Dr Jennifer Shelton
Molecular Ecologist, UK Centre for Ecology & Hydrology
A High-Level Survey of One Health AMR and the Tensions between pragmatism, principles and politics in deciding how we will survive
Dr Mark Sutton
Scientific Leader, UKHSA and Professor for Antimicrobial Therapy, Kings College London
Supporting Innovation and Influence as part of the National Action Plan for Antimicrobial Resistance; Open Innovation in AMR – a case study
Clinical perspectives
Prof Ben Chew
Associate Professor and Director of Clinical Research, Department of Urologic Sciences, University of British Columbia
Infections and Sepsis from Ureteral stents, Ureteroscopy and Percutaneous Nephrolithotomy
Prof Gail Hayward
Nuffield Department of Primary Care Health Sciences, Oxford University
6 million prescriptions: Antibiotic stewardship approaches for community UTI
Prof Ashok Handa
Professor of Vascular Surgery, Nuffield Department of Surgical Sciences, Oxford University
Research updates
Prof Christopher Schofield
Director of Chemistry, Ineos Oxford Institute for antimicrobial research, Oxford University
New antibiotics needs new people and new ideas
Prof Eleanor Stride
Principal Investigator, Beyond Antibiotics, Department of Engineering Science, Oxford University
Prof Craig MacLean
Senior Research Fellow, All Souls College and Professor of Evolution and Microbiology, Oxford University
Chair of the Oxford AMR Network
Chair of the Oxford AMR Network
What should we target? Insights from evolutionary biology
Industrial perspectives
Dr Mark Wilkinson
Co-founder and Chief Scientific Officer, Bactobio
Discovery of novel antimicrobials from uncultured microbes
Dr Emma Hayhurst
Chief Executive Officer, Llusern Scientific
Developing a point of care test for UTI
Dr Bart Gottenbos
Senior Scientist, Philips Oral Healthcare, Front-End Innovation
Targeting oral biofilm for preventive health
Prof Constantin Coussios,
Director, Institute of Biomedical Engineering and Statutory Chair of Biomedical Engineering
Dr Man-Wah Tan
Vice President and Senior Fellow, Genentech, A Member of the Roche Group
Translating natural designs into novel antibiotic classes
Dr Daniel Metcalf
Director, Medical Scientific Liaison, Convatec
Bringing next-generation antibiofilm wound dressing platforms to market – past and present experiences
Engagement and awareness
Prof Diane Ashiru-Oredope
Lead Pharmacist for healthcare-associated infections, UKSHA
Dr Kate Grailey
Behavioural Science Lead, Fleming Initiative
Prof Jennifer Rohn
Head of the Centre for Urological Biology, University College London
International Research
Dr Freya Harrison
Reader in Microbiology, School of Life Sciences, University of Warwick
An open science approach to clinical biofilm research
Prof Michel Versluis
Professor of Physical and Medical Acoustics, University of Twente, The Netherlands
Bubble, bubble, toil and trouble
Dr Kirsty Sands
Scientific lead, Global Surveillance of Antimicrobial Resistance Research, Ineos Oxford Institute for antimicrobial research, Oxford University
Klebsiella pneumoniae neonatal sepsis in low- and middle-income countries
Prof Dirk Lange
Associate Professor, Faculty of Medicine, The University of British Columbia
Novel antimicrobial approaches to prevent indwelling urinary device associated infection
Dr Amelia (Annie) Joseph
Consultant Medical Microbiologist & Antimicrobial Stewardship Lead, Nottingham University Hospitals NHS Trust
Opportunities and challenges of non-antibiotic options for UTI – Cases from the Nottingham Complex UTI Clinic
In partnership with Beyond antibiotics
